Momo Group Inc. – Trademark Portfolio
Entity Type: 03
Momo Group Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. Currently, 2 trademarks are registered and 2 are pending. Notable registered marks include GREYCOAT and DEAR GREY COAT. The owner is based in Seongnam-si.
Seongnam-si, Gyeonggi-do
403-1, 4F, 100 Jeongjail-ro, Bundang-gu
Seongnam-si 13562 , KR
Showing of trademarks Trademarks
Trademark Classifications
Momo Group Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Frequently Asked Questions
How many trademarks does Momo Group Inc. have?
Momo Group Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 pending, 1 abandoned.
What trademark classes does Momo Group Inc. file in?
Momo Group Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 31 (Natural Agricultural Products). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Momo Group Inc.'s most well-known trademarks?
Momo Group Inc.'s registered trademark portfolio includes well-known marks such as GREYCOAT and DEAR GREY COAT. These are among 2 currently registered trademarks in the portfolio.
What is Momo Group Inc.'s trademark registration success rate?
Momo Group Inc. has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 2 applications are pending review.